StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories abbott India Limited — Revenue from Operations (INR Crores)

Abbott India Limited (NSE: ABBOTINDIA) Quarterly & Annual Filings

QuarterlyAnnual
Latest, Q2 2026
1,814
Period ended Jun 30, 2026
Change on a year earlier
+4.4%
1,738 in Q2 2025
History
13 quarters
Since Q2 2023
Sources
1
Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in)

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAbbott India Limited — Revenue from Operations (INR Crores)Year on yearSource
Q2 2026Jun 30, 20261,814+4.4%Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q1 2026Mar 31, 20261,710+6.5%Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q4 2025Dec 31, 20251,724+6.8%Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q3 2025Sep 30, 20251,757+7.6%Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q2 2025Jun 30, 20251,738+11.6%Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q1 2025Mar 31, 20251,605+11.5%Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q4 2024Dec 31, 20241,614+12.3%Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q3 2024Sep 30, 20241,633+9.3%Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q2 2024Jun 30, 20241,558+5.3%Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q1 2024Mar 31, 20241,439–Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q4 2023Dec 31, 20231,437–Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q3 2023Sep 30, 20231,494–Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q2 2023Jun 30, 20231,479–Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗

Breakdown

What makes up abbott india limited — revenue from operations (inr crores)

Cite this data

StockData. (2026). Abbott Laboratories Abbott India Limited — Revenue from Operations (INR Crores), quarterly Q2 2023–Q2 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/ind-sales

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.